BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 23953944)

  • 21. Intermediary metabolism during the development of obesity and diabetes in the desert rodent Acomys cahirinus.
    Shafrir E
    Int J Obes; 1982; 6 Suppl 1():9-20. PubMed ID: 7118367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
    Freund P; Wolff HP; Kühnle HF
    Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Achievements in molecular genetics studies of diabetes mellitus].
    Pankov IuA
    Biomed Khim; 2005; 51(2):107-17. PubMed ID: 15945346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.
    Watts LM; Manchem VP; Leedom TA; Rivard AL; McKay RA; Bao D; Neroladakis T; Monia BP; Bodenmiller DM; Cao JX; Zhang HY; Cox AL; Jacobs SJ; Michael MD; Sloop KW; Bhanot S
    Diabetes; 2005 Jun; 54(6):1846-53. PubMed ID: 15919808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related changes in hepatic glycogen metabolism in the genetically diabetic (db/db) mouse.
    Roesler WJ; Khandelwal RL
    Diabetes; 1985 Apr; 34(4):395-402. PubMed ID: 2982686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic glucose-6-phosphatase activities and correlated ultrastructural alterations in hepatocytes of diabetic rats.
    Garfield SA; Cardell RR
    Diabetes; 1979 Jul; 28(7):664-79. PubMed ID: 221299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols.
    Elased KM; Gumaa KA; de Souza JB; Playfair JH; Rademacher TW
    Metabolism; 2004 Aug; 53(8):1048-53. PubMed ID: 15281017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arbutin ameliorates hyperglycemia, dyslipidemia and oxidative stress and modulates adipocytokines and PPARγ in high-fat diet/streptozotocin-induced diabetic rats.
    Abduh MS; Alzoghaibi MA; Alzoghaibi AM; Bin-Ammar A; Alotaibi MF; Kamel EM; Mahmoud AM
    Life Sci; 2023 May; 321():121612. PubMed ID: 36948387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
    Tang Y; Osawa H; Onuma H; Nishimiya T; Ochi M; Makino H
    Diabetes; 1999 Sep; 48(9):1830-5. PubMed ID: 10480615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PSTPIP2 alleviates obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through promoting M2 macrophage polarization via activation of PPARγ.
    Xu J; Lv H
    J Diabetes Complications; 2023 Jun; 37(6):108479. PubMed ID: 37150118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
    Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes.
    Wu C; Okar DA; Newgard CB; Lange AJ
    Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E38-45. PubMed ID: 11739081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible role of age-related increase in the plasma glucagon/insulin ratio in the enhanced hepatic gluconeogenesis and hyperglycemia in genetically diabetic (C57BL/KsJ-db/db) mice.
    Kodama H; Fujita M; Yamazaki M; Yamaguchi I
    Jpn J Pharmacol; 1994 Nov; 66(3):281-7. PubMed ID: 7869614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor.
    Metzger S; Nusair S; Planer D; Barash V; Pappo O; Shilyansky J; Chajek-Shaul T
    Endocrinology; 2004 Nov; 145(11):5150-6. PubMed ID: 15297440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
    Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake.
    Sandu O; Song K; Cai W; Zheng F; Uribarri J; Vlassara H
    Diabetes; 2005 Aug; 54(8):2314-9. PubMed ID: 16046296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a high carbohydrate diet on adipocyte glucose metabolism in spontaneously obese rats and insulin-deficient diabetic rats.
    Saekow M; Olefsky JM
    Endocrinology; 1980 Dec; 107(6):2004-10. PubMed ID: 7428703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term fat-feeding-induced insulin resistance in normal NMRI mice: postreceptor changes of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes.
    Hedeskov CJ; Capito K; Islin H; Hansen SE; Thams P
    Acta Diabetol; 1992; 29(1):14-9. PubMed ID: 1520900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs.
    Renner S; Blutke A; Dobenecker B; Dhom G; Müller TD; Finan B; Clemmensen C; Bernau M; Novak I; Rathkolb B; Senf S; Zöls S; Roth M; Götz A; Hofmann SM; Hrabĕ de Angelis M; Wanke R; Kienzle E; Scholz AM; DiMarchi R; Ritzmann M; Tschöp MH; Wolf E
    Mol Metab; 2018 Oct; 16():180-190. PubMed ID: 30017782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic features of AdipoAI, a novel AdipoR agonist.
    Ahuja A; Zboinski E; das S; Zhu X; Ma Q; Xie Y; Tu Q; Chen J
    Cell Biochem Funct; 2024 Jan; 42(1):e3910. PubMed ID: 38269524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.